Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo
CA 2295925 A1 · Owner: Karolinska Innovations Ab · Inventors: Yihai, Cao
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a protein capable of regulating the endothelian cell proliferation as well as various uses thereof. The protein according to the invention has a molecular weight of approximately 50-60 kDa preferably about 55 kDa, and has an amino acid sequence which is , substantially similar to that of a plasminogen fragment comprised of Lys 78- Arg 530 of a plasminogen molecule.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 26, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 26, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 26, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.